×
Top Dividend Stocks to Buy before the prices go up!
Download Your Free Stock Report!
Our expert team of analysts helps you with Buy, Hold & Sell recommendations!
Our goal is to provide you with best stock market recommendations At the Right Price - At the Right Time
To Get Free Reports Register Now
Register Now
By clicking this button, you agree to our
Terms of Service
and
Privacy Policy
& our Financial Services Guide
(FSG)
×
7 Days Free Trial
Submit
info@aceinvestors.com.au
(02) 9199 9639
Members Login
Contact Us
Home
Research Reports
Daily Recommendations
Dividend Income Report
Growth Stock Report
Speculative Stock Report
US Stock Report
Under 50 cents Special
US Market Report
Segment Specific
Blue Chip
Mid Cap
Small Cap
IPO
Sector Coverage
Banking
Entertainment
Financials
Telecom
Healthcare
Food, Beverage & Tobacco
Insurance
Services and Materials
Technology & IT
IPO
Mining
Energy
Media
Industrial
Utility
Retail
Real Estate
Airlines & Transportation
Consumer Discretionary
Editorial
Sample Report
Subscribe
Privacy Policy
Home
Privacy Policy
PharmAust Limited: Clinical Trial Delivers Pr...
By ACE Investors / 25 Sep 2020
Read More
Immutep Limited: Worldwide Leader in Developi...
By ACE Investors / 24 Sep 2020
Read More
Paradigm Biopharmaceuticals Limited: Well Fun...
By ACE Investors / 22 Sep 2020
Read More
Resmed Inc: Focus on Increasing SaaS Business...
By ACE Investors / 21 Sep 2020
Read More
Orthocell Limited: Well Established to Progre...
By ACE Investors / 11 Sep 2020
Read More
Volpara Health Technologies Limited: Continue...
By ACE Investors / 10 Sep 2020
Read More
Medical Developments International Limited: S...
By ACE Investors / 09 Sep 2020
Read More
Kazia Therapeutics Limited – Management Inc...
By ACE Investors / 07 Sep 2020
Read More
Cynata Therapeutics Limited – Significant C...
By ACE Investors / 07 Sep 2020
Read More
Pharmaxis Limited – Strong Small Cap Drug D...
By ACE Investors / 04 Sep 2020
Read More
MGC Pharmaceuticals Limited – Leading the W...
By ACE Investors / 31 Aug 2020
Read More
Osteopore Limited: Why This Nascent Medical D...
By ACE Investors / 28 Aug 2020
Read More
‹ First
<Previous
39
40
41
42
43
Next >
Last ›
ABN No: 70 637 702 188 | ACN NO: 637 702 188
Copyright © 2024 ACE Investors. All Right Reserved. Design by
Ace Investors